Beyond the Board: What Companies Need to Know Before Entering the MilAero PCB Market
Defense Speak Interpreted: If CHIPS Cuts Back, What Happens to Electronics Packaging Funds?
American Made Advocacy: Where’s the Budget for a Modern Military Run on Microelectronics?
Cicor Acquires Evolution Medtec Srl, Strengthens Engineering Capabilities in Medtech Sector
February 28, 2024 | Cicor Technologies Ltd.Estimated reading time: 1 minute
The Cicor Group has acquired 100% of the shares of the Romanian engineering company Evolution Medtec Srl and is further expanding its engineering capabilities in the medical technology sector.
Evolution Medtec is a provider of comprehensive engineering services with a strong focus on medical and paramedical applications. The company has been active in the development and prototyping of medtech applications for 20 years and currently employs 25 people in Bucharest, Romania. The FDA registered site is ISO 13485 certified. In the last fiscal year, Evolution Medtec generated sales in the lower single-digit million Euro range with an EBITDA margin comparable to the Cicor Group. Evolution Medtec's longstanding customers are medium and large medical device and industrial companies in Europe, the UK, and the US.
Cicor is one of Europe's fastest-growing developers and manufacturers of high-reliability electronics for the medical, industrial, aerospace and defence markets. With the acquisition of Evolution Medtec, Cicor further strengthens its engineering expertise and capacity in the strategically important medical technology market. Cicor will continue to provide first-class development services at Evolution Medtec's existing site under the leadership of the existing management team.
With the acquisition of Evolution Medtec and STS Defence (transaction completed in January 2024), Cicor has created one of the strongest R&D platforms in the European EMS industry, doubling the resources to develop highly advanced electronic solutions for the medical, industrial, aerospace and defence markets.
Share on:
Testimonial
"We’re proud to call I-Connect007 a trusted partner. Their innovative approach and industry insight made our podcast collaboration a success by connecting us with the right audience and delivering real results."
Julia McCaffrey - NCAB GroupSuggested Items
Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing Healthcare Innovation
09/17/2025 | PRNewswireThe global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
09/15/2025 | GlobeNewswireArmstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.
Nordson MEDICAL Divests Contract Manufacturing, Refocuses on Proprietary Components
09/03/2025 | BUSINESS WIRENordson Corporation has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
Medical Device Contract Manufacturing Market Worth $140.84 Billion by 2030 with 10.9% CAGR
08/25/2025 | PRNewswireThe global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
TT Electronics Achieves ISO 13485 Medical Certification at Mexicali EMS Facility
06/27/2025 | TT ElectronicsThis milestone underscores TT Electronics’ commitment to delivering high-quality, compliant, and reliable manufacturing solutions to its global customers in healthcare and life sciences.